HJM-561, a potent, selective and orally bioavailable EGFR PROTAC that overcomes osimertinib-resistant EGFR triple mutations.
暂无分享,去创建一个
Zhaofu Wang | Li Zhang | Jinju Chen | Guozhong Ye | Xiaorong Lu | Yan Li | George Zhang | Yong Du | Yongfeng Chen | Yuxia Wang